Clinical Trials Logo
  1. Home
  2. Ureter Injury
  3. NCT03387410

Ureter Identification With IRDye 800BK

Ureter Injury Clinical Trial

Official title:
Safety and Efficacy of IRDye 800BK in Ureter Identification Via Fluorescence Detection During Laparoscopic Abdominal Surgery

Clinical Trial Summary

Phase 1/2a study, second in-man utilising IRDye800BK in ureteric identification using fluorescence throughout abdominal surgery. Study is open label, non-randomised prospective study.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03387410
Study type Interventional
Source Oxford University Hospitals NHS Trust
Contact
Status Completed
Phase Phase 1/Phase 2
Start date April 6, 2018
Completion date November 16, 2018
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05640115 - Obstruction of Malignancy: Percutaneous Renal vs Endoscopic Stent Early Phase 1
Recruiting NCT06054880 - Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency Phase 4
Completed NCT03937505 - A Safety and Efficacy Study of IS-001 Injection in Patients Undergoing Robotic Hysterectomy Phase 2
Not yet recruiting NCT06448143 - Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency in Pediatric Patients Phase 3
Completed NCT05769257 - A Safety and Feasibility Study of IS-001 Injection in Patients Undergoing Robotic Colorectal Surgery Phase 2
Recruiting NCT06278753 - Comparison of Standard Cystoscopy With Carbon Dioxide Cystoscopy
Recruiting NCT05954767 - IS-001 Injection in Patients Undergoing Robotic-Assisted Gynecological Surgery Phase 3
Completed NCT04228445 - 3,3'-Dioxo-2,2'-Bisindolylidene-5,5'-Disulfonate Disodium 0.8% Solution as an Aid for Ureteral Patency Phase 3
Recruiting NCT06085183 - Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency in Patient's With Renal Impairment Phase 4